Literature DB >> 28589522

Virtopsy shows a high status funerary treatment in an early 18th Dynasty non-royal individual.

Robert D Loynes1, Philippe Charlier2,3, Philippe Froesch2, Tobias M R Houlton4, Rudy Lallo5, Giancarlo Di Vella6, Raffaella Bianucci6,7,8.   

Abstract

This work presents the multidisciplinary investigation of the head of Nebiri (Museo Egizio, Turin S_5109), Chief of Stables, a high status elite person from the 18th Dynasty involving MDCT, 3D brain surface and facial reconstructions accompanied by a consideration of previously presented chemical analysis of the embalming materials found in fragments of bandages used on the head and viscera (lung) found in one of the four canopic jars. Comparison of the techniques used for the cosmetic treatment of Nebiri with those used in other elite and high status non-royal persons confirms the validity of the use of the term "high status elite" in the case of Nebiri. This case highlights the importance of using modern forensic techniques both to enhance new technologies of retrospective diagnosis on altered human remains and to increase knowledge of past populations.

Entities:  

Keywords:  3D brain surface reconstruction; 3D facial approximation; Human remains; MDCT

Mesh:

Year:  2017        PMID: 28589522     DOI: 10.1007/s12024-017-9879-0

Source DB:  PubMed          Journal:  Forensic Sci Med Pathol        ISSN: 1547-769X            Impact factor:   2.007


  18 in total

1.  Ultrasonic assessment of facial soft tissue thicknesses in adult Egyptians.

Authors:  I H El-Mehallawi; E M Soliman
Journal:  Forensic Sci Int       Date:  2001-03-01       Impact factor: 2.395

2.  Embalming was used in Old Kingdom.

Authors:  J Koller; U Baumer; Y Kaup; H Etspüler; U Weser
Journal:  Nature       Date:  1998-01-22       Impact factor: 49.962

3.  3-dimensional brain surface reconstruction from dried skull: interest for retrospective diagnosis in forensic anthropology.

Authors:  Philippe Charlier; Philippe Froesch; Antoine Balzeau; Isabelle Huynh-Charlier
Journal:  Am J Forensic Med Pathol       Date:  2014-12       Impact factor: 0.921

4.  Subcutaneous packing in royal Egyptian mummies dated from 18th to 20th dynasties.

Authors:  Sahar N Saleem; Zahi Hawass
Journal:  J Comput Assist Tomogr       Date:  2015 May-Jun       Impact factor: 1.826

5.  Variability in brain treatment during mummification of royal Egyptians dated to the 18th-20th dynasties: MDCT findings correlated with the archaeologic literature.

Authors:  Sahar N Saleem; Zahi Hawass
Journal:  AJR Am J Roentgenol       Date:  2013-04       Impact factor: 3.959

6.  Studies of organic residues from ancient Egyptian mummies using high temperature-gas chromatography-mass spectrometry and sequential thermal desorption-gas chromatography-mass spectrometry and pyrolysis-gas chromatography-mass spectrometry.

Authors:  S A Buckley; A W Stott; R P Evershed
Journal:  Analyst       Date:  1999-04       Impact factor: 4.616

7.  Forensic Analysis Reveals Acute Decompensation of Chronic Heart Failure in a 3500-Year-Old Egyptian Dignitary.

Authors:  Raffaella Bianucci; Robert D Loynes; M Linda Sutherland; Rudy Lallo; Gemma L Kay; Philippe Froesch; Mark J Pallen; Philippe Charlier; Andreas G Nerlich
Journal:  J Forensic Sci       Date:  2016-06-30       Impact factor: 1.832

8.  Complex organic chemical balms of Pharaonic animal mummies.

Authors:  Stephen A Buckley; Katherine A Clark; Richard P Evershed
Journal:  Nature       Date:  2004-09-16       Impact factor: 49.962

9.  Shedding New Light on the 18th Dynasty Mummies of the Royal Architect Kha and His Spouse Merit.

Authors:  Raffaella Bianucci; Michael E Habicht; Stephen Buckley; Joann Fletcher; Roger Seiler; Lena M Öhrström; Eleni Vassilika; Thomas Böni; Frank J Rühli
Journal:  PLoS One       Date:  2015-07-22       Impact factor: 3.240

10.  Evidence for prehistoric origins of Egyptian mummification in late Neolithic burials.

Authors:  Jana Jones; Thomas F G Higham; Ron Oldfield; Terry P O'Connor; Stephen A Buckley
Journal:  PLoS One       Date:  2014-08-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.